3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
2
Thoracic
1
Genitourinary
1
Breast
1
Conditions
Breast Neoplasms
15
Carcinoma, Ductal, Breast
4
Carcinoma, Intraductal, Noninfiltrating
3
Breast Carcinoma In Situ
3
Prostatic Neoplasms
1
Neoplasms
1
Melanoma
1
Lung Neoplasms
1
Carcinoma, Lobular
1
Carcinoma, Ductal
1
Interventions
pembrolizumab
44
Cyclophosphamide
21
Nivolumab
18
fludarabine
10
durvalumab
8
Paclitaxel
8
Magnetic Resonance Spectroscopy
8
Interleukin-2
8
Docetaxel
8
aldesleukin
7
Radiosurgery
7
Ipilimumab
7
spartalizumab
6
poly ICLC
6
fludarabine phosphate
6
atezolizumab
6
Specimen Handling
6
Radiotherapy
6
Carboplatin
6
cemiplimab
5
Drug Therapy
5
Cisplatin
5
Biopsy
5
Temozolomide
4
Immune Checkpoint Inhibitors
4
tremelimumab
3
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
3
pazopanib
3
avelumab
3
Trastuzumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Melanoma
×
Brachytherapy
×
Breast
×
Clear all
NCT01777802
2025-08-27
SBRT
Mayo Clinic
Completed
98 enrolled